94 related articles for article (PubMed ID: 3347790)
1. [Effect of various roentgen contrast media on pancreatic and liver enzymes in ERCP].
Rambow A; Staritz M; Manns M; Hütteroth T; Meyer zum Büschenfelde KH
Schweiz Rundsch Med Prax; 1988 Jan; 77(4):55-7. PubMed ID: 3347790
[No Abstract] [Full Text] [Related]
2. Adverse reactions to intravenous cholangiography with Biligram.
Hald JK
Eur J Radiol; 1984 Aug; 4(3):196-7. PubMed ID: 6468411
[TBL] [Abstract][Full Text] [Related]
3. Contrast media for ERCP.
Rambow A; Staritz M; Meyer zum Büschenfelde KH
Endoscopy; 1988 May; 20(3):126-7. PubMed ID: 3383805
[No Abstract] [Full Text] [Related]
4. [New contrast media for angiography (Telebrix, Hexabrix) (author's transl)].
Bohutová J; Kolár J; Karmazin V; Stupáková Z
Cas Lek Cesk; 1981; 120(50):1527-30. PubMed ID: 7326714
[No Abstract] [Full Text] [Related]
5. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
Short TP; Thomas E
Am J Gastroenterol; 1992 May; 87(5):682-3; author reply 684-5. PubMed ID: 1595669
[No Abstract] [Full Text] [Related]
6. [Intravenous cholegraphy: image quality and side effects of 3 contrast media - a comparison].
Marions O; Pyk E; Wiechel KL
Lakartidningen; 1980 May; 77(20):1948-9. PubMed ID: 7392731
[No Abstract] [Full Text] [Related]
7. [The results and tolerability of infusion cholegraphy using ioglycamide-85 (12.75 g meglumine salt in 75 ml) in comparison with the use of a hypotonic adipiodone solution (10 g meglumine salt in 100 ml)].
Ronneburg HP
Radiol Diagn (Berl); 1990; 31(3):253-60. PubMed ID: 2367631
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions at intravenous cholegraphy with ioglycamide. Correlation with the level of circulating sex hormones.
Wirell S
Acta Radiol Diagn (Stockh); 1982; 23(4):405-7. PubMed ID: 7158403
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis following phlebography with high-osmolar and low-osmolar contrast media.
Eliasen B; Hørup A; Jensen AR
Eur J Radiol; 1983 May; 3(2):97-8. PubMed ID: 6347689
[TBL] [Abstract][Full Text] [Related]
10. [Transient hypothyroidism following administration of roentgen contrast media to the newborn and infants].
Röhner G; Rautenburg HW
Med Welt; 1983 Jun; 34(23):668-70. PubMed ID: 6877078
[No Abstract] [Full Text] [Related]
11. [Sudden death after "Billigram" infusion in Waldenstrom's disease].
Bauer G; Bauer K; Tragl KH
Beitr Gerichtl Med; 1975; 33():160-5. PubMed ID: 816347
[No Abstract] [Full Text] [Related]
12. Intravenous contrast media in Waldenströms macroglobulinaemia and related disorders: a potentially harmful investigation?
Dammacco F; Valente A; Fucci G; Buonanno G
Haematologica; 1977 Jun; 62(3):279-87. PubMed ID: 408241
[No Abstract] [Full Text] [Related]
13. [Painless angiography of arteriovenous shunts for hemodialysis. Value of ioxaglic acid].
Moreau JF; Dana A; Sterin P; Schmit P; Michel JR
Nouv Presse Med; 1980 Mar; 9(13):965. PubMed ID: 7360632
[No Abstract] [Full Text] [Related]
14. Gadolinium as an alternative contrast agent for therapeutic ERCP in the iodine-allergic patient.
Lawrence C; Cotton PB
Endoscopy; 2009 Jun; 41(6):564-7. PubMed ID: 19533564
[TBL] [Abstract][Full Text] [Related]
15. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
Limido G
Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
[No Abstract] [Full Text] [Related]
16. Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP.
Draganov PV; Forsmark CE
Gastrointest Endosc; 2008 Dec; 68(6):1098-101. PubMed ID: 19028218
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
[TBL] [Abstract][Full Text] [Related]
18. Urography with non-ionic contrast media: II. Diagnostic quality and tolerance of iopromide in comparison with ioxaglate.
Taenzer V; Meiisel P; Hartwig P
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():153-5. PubMed ID: 6139071
[No Abstract] [Full Text] [Related]
19. [A life-threatening contrast-medium reaction during ERCP].
Zimmerer J; Mainos D; Tittor W; Spannagel B
Dtsch Med Wochenschr; 1990 Jul; 115(27):1077-8. PubMed ID: 2364886
[No Abstract] [Full Text] [Related]
20. Formulation and clinical introduction of low osmolality contrast media.
Grainger RG
Radiologe; 1981 Jun; 21(6):261-7. PubMed ID: 7268025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
